Cytomegalovirus-specific antibody responses in renal transplant patients with primary and recurrent CMV infections
✍ Scribed by Dr. H. J. O'Neill; P. V. Shirodaria; J. H. Connolly; D. I. H. Simpson; Mary G. McGeown
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 606 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Cytomegalovirus‐specific in vitro antibody production (CMV‐IVAP) by peripheral blood lymphocytes (PBL) was investigated in 12 renal transplant recipients. CMV‐IVAP, CMV‐serology, and viral cultures were carried out weekly during at least 8 weeks after transplantation. Nine episodes of C
## Abstract The early activation of T‐ and B‐cell responses to cytomegalovirus was studied in immunosuppressed patients. Primary lymphocyte stimulation to cytomegalovirus (CMV) antigen, a measure of T‐helper activity, and anti‐CMV IgG subclass responses were analyzed. Ten patients suffering from pr
Natural killer (NK) cell function in relation t o immunophenotypical signs of NK activation was studied prospectively in 15 renal transplant patients with cytomegalovirus (CMV) infection. NK activity (expressed as the percentage of K562 ly- sis) before onset of CMV infection reached a median of 6% (
The value of IgM detection for the early diagnosis of an active cytomegalovirus (CMV) infection in renal transplant recipients was evaluated prospectively. Sequential serum samples obtained from 22 allograft recipients with active CMV infection were tested for the presence of CMV-specific immunoglob
## Abstract We studied the recovery of CMV‐specific CD4^+^ and CD8^+^ T‐cell immunity in 52 recipients of allogeneic stem cell transplantation (SCT). The proportions of IFN‐γ‐producing CD4^+^ and CD8^+^ T cells upon in vitro activation using peptide pools representing the CMV pp65 and IE‐1 proteins